The combined effects of oncolytic reovirus plus Newcastle disease virus and reovirus plus parvovirus on U87 and U373 cells in vitro and in vivo

Journal of Neuro-Oncology

Volumn 104, Issue 3, 2011, Pages 715-727

  Alkassar, Muhannad ^a   Gärtner, Barbara ^a   Roemer, Klaus ^a   Graesser, Friedrich ^a   Rommelaere, Jean ^b   Kaestner, Lars ^a   Haeckel, Isabelle ^a   Graf, Norbert ^a  

^a SAARLAND UNIVERSITY   (Germany)

^b F010/INSERM Unit 701   (Germany)

Author keywords

Combination of oncolytic viruses; Glioblastoma; Newcastle disease virus; Parvovirus; Reovirus

Indexed keywords

ONCOLYTIC NEWCASTLE DISEASE PARAMYXOVIRUS; ONCOLYTIC PARVOVIRUS; ONCOLYTIC REOVIRUS; ONCOLYTIC VIRUS; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; CYTOSKELETON; DRUG EFFICACY; DRUG POTENTIATION; FEMALE; FLOW CYTOMETRY; GLIOBLASTOMA; GLIOMA; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; ONCOLYTIC VIROTHERAPY; PROTEIN LOCALIZATION; REOVIRUS; SIGNAL TRANSDUCTION; VIRUS LOAD; VIRUS REPLICATION; VIRUS TITRATION;

ANIMALS; BRAIN; BRAIN NEOPLASMS; CELL DEATH; CELL LINE, TUMOR; CULTURE MEDIA; DISEASE MODELS, ANIMAL; FEMALE; FLOW CYTOMETRY; GLIOMA; HUMANS; MICE; MICE, SCID; NEWCASTLE DISEASE VIRUS; ONCOLYTIC VIRUSES; PARVOVIRUS; TETRAZOLIUM SALTS; THIAZOLES; VIRAL LOAD; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 80052615453     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-011-0606-5     Document Type: Article

References (56)

1. D Krex B Klink C Hartmann A von Deimling T Pietsch M Simon M Sabel JP Steinbach O Heese G Reifenberger M Weller G Schackert 2007 Long-term survival with glioblastoma multiforme Brain 130 Pt 10 2596 2606 17785346 10.1093/brain/awm204 (Pubitemid 47511715)
2. DT Blumenthal SF Schulman 2005 Survival outcomes in glioblastoma multiforme, including the impact of adjuvant chemotherapy Expert Rev Neurother 5 5 683 690 16162092 10.1586/14737175.5.5.683 (Pubitemid 41431427)
3. M Lacroix D Abi-Said DR Fourney ZL Gokaslan W Shi F DeMonte FF Lang IE McCutcheon SJ Hassenbusch E Holland K Hess C Michael D Miller R Sawaya 2001 A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival J Neurosurg 95 2 190 198 11780887 10.3171/jns.2001.95.2.0190 1:STN:280:DC%2BD38%2FlsFGitA%3D%3D (Pubitemid 32799739)
4. RG Everson M Gromeier JH Sampson 2007 Viruses in the treatment of malignant glioma Expert Rev Neurother 7 4 321 324 17425484 10.1586/14737175.7.4. 321 1:CAS:528:DC%2BD2sXkt1Wqsrw%3D (Pubitemid 46623354)
5. Y Ino T Todo 2009 Oncolytic virus therapy for malignant brain tumors Brain Nerve 61 7 815 822 19618859 1:CAS:528:DC%2BD1MXhtFCgtLzJ
6. NG Rainov H Ren 2003 Oncolytic viruses for treatment of malignant brain tumours Acta Neurochir 88 113 123 1:STN:280:DC%2BD3svmvFertQ%3D%3D
7. A Haseley C Alvarez-Breckenridge AR Chaudhury B Kaur 2009 Advances in oncolytic virus therapy for glioma Recent Patents CNS Drug Discov 4 1 1 13 10.2174/157488909787002573 1:CAS:528:DC%2BD1MXkslCksLY%3D
8. MS Roberts RM Lorence WS Groene MK Bamat 2006 Naturally oncolytic viruses Curr Opin Mole Ther 8 4 314 321 (Pubitemid 44256365)
9. I Arrese P Gonzalez P Miranda A Perez-Nunez B Pascual RD Lobato 2005 Oncolytic viral therapy of gliomas: review of the literature Neurocirugia (Asturias, Spain) 16 2 158 168 1:STN:280:DC%2BD2MzktVKntA%3D%3D (Pubitemid 40745466)
10. R Cavaliere H Newton 2006 Cytotoxic and molecular chemotherapy for high-grade glioma: an emerging strategy for the future Expert Opin Pharmacother 7 6 749 765 16556090 10.1517/14656566.7.6.749 1:CAS:528:DC%2BD28XivVOnu7o%3D
11. JG Sinkovics JC Horvath 2008 Natural and genetically engineered viral agents for oncolysis and gene therapy of human cancers Arch Immunol Ther Exp 56 Suppl 1 3 59 1:CAS:528:DC%2BD1MXktFClsL4%3D
12. JE Strong MC Coffey D Tang P Sabinin PW Lee 1998 The molecular basis of viral oncolysis: usurpation of the Ras signaling pathway by reovirus EMBO J 17 12 3351 3362 9628872 10.1093/emboj/17.12.3351 1:CAS:528:DyaK1cXksFCltL8%3D (Pubitemid 28279509)
13. RS Noyce SE Collins KL Mossman 2009 Differential modification of interferon regulatory factor 3 following virus particle entry J Virol 83 9 4013 4022 19211751 10.1128/JVI.02069-08 1:CAS:528:DC%2BD1MXlt1Kqt7Y%3D
14. PV Ravindra AK Tiwari B Ratta U Chaturvedi SK Palia RS Chauhan 2009 Newcastle disease virus-induced cytopathic effect in infected cells is caused by apoptosis Virus Res 141 1 13 20 19152817 10.1016/j.virusres.2008.12.008 1:CAS:528:DC%2BD1MXivVCrt7k%3D
15. PY Lin HJ Liu MH Liao CD Chang CI Chang HL Cheng JW Lee WL Shih 2010 Activation of PI 3-kinase/Akt/NF-kappaB and Stat3 signaling by avian reovirus S1133 in the early stages of infection results in an inflammatory response and delayed apoptosis Virology 400 1 104 114 20170934 10.1016/j.virol.2010.01.024 1:CAS:528:DC%2BC3cXjtVCqsbc%3D
16. M Di Piazza C Mader K Geletneky YCM Herrero E Weber J Schlehofer L Deleu J Rommelaere 2007 Cytosolic activation of cathepsins mediates parvovirus H-1-induced killing of cisplatin and trail-resistant glioma cells J Virol 81 8 4186 4198 17287256 10.1128/JVI.02601-06 1:CAS:528:DC%2BD2sXksVKksLY%3D (Pubitemid 46586913)
17. G Wollmann P Tattersall AN van den Pol 2005 Targeting human glioblastoma cells: comparison of nine viruses with oncolytic potential J Virol 79 10 6005 6022 15857987 10.1128/JVI.79.10.6005-6022.2005 1:CAS:528:DC%2BD2MXkt1Wit7s%3D (Pubitemid 40617207)
18. AL Pecora N Rizvi GI Cohen NJ Meropol D Sterman JL Marshall S Goldberg P Gross JD O'Neil WS Groene MS Roberts H Rabin MK Bamat RM Lorence 2002 Phase I trial of intravenous administration of PV701, an oncolytic virus, in patients with advanced solid cancers J Clin Oncol 20 9 2251 2266 11980996 10.1200/JCO.2002.08.042 1:CAS:528:DC%2BD38XktVKrs74%3D (Pubitemid 34441652)
19. T Alain M Kim RN Johnston S Urbanski AE Kossakowska PA Forsyth PW Lee 2006 The oncolytic effect in vivo of reovirus on tumour cells that have survived reovirus cell killing in vitro Br J Cancer 95 8 1020 1027 17047650 10.1038/sj.bjc.6603363 1:CAS:528:DC%2BD28XhtVyitbbO (Pubitemid 44606828)
20. B Kaina M Christmann S Naumann WP Roos 2007 MGMT: Key node in the battle against genotoxicity, carcinogenicity and apoptosis induced by alkylating agents DNA repair 6 8 1079 1099 17485253 10.1016/j.dnarep.2007.03.008 1:CAS:528:DC%2BD2sXotVamtrc%3D (Pubitemid 47058389)
21. S Kumar L Gao B Yeagy T Reid 2008 Virus combinations and chemotherapy for the treatment of human cancers Curr Opin Mole Ther 10 4 371 379
22. K Twigger L Vidal CL White JS De Bono S Bhide M Coffey B Thompson RG Vile L Heinemann HS Pandha F Errington AA Melcher KJ Harrington 2008 Enhanced in vitro and in vivo cytotoxicity of combined reovirus and radiotherapy Clin Cancer Res 14 3 912 923 18245555 10.1158/1078-0432.CCR-07-1400 1:CAS:528: DC%2BD1cXhsFyktLY%3D (Pubitemid 351231176)
23. K Collins T Jacks NP Pavletich 1997 The cell cycle and cancer Proc Natl Acad Sci USA 94 7 2776 2778 9096291 10.1073/pnas.94.7.2776 1:CAS:528: DyaK2sXisVKhu7k%3D (Pubitemid 27157209)
24. NL Lehman R Tibshirani JY Hsu Y Natkunam BT Harris RB West MA Masek K Montgomery M van de Rijn PK Jackson 2007 Oncogenic regulators and substrates of the anaphase promoting complex/cyclosome are frequently overexpressed in malignant tumors Am J Pathol 170 5 1793 1805 17456782 10.2353/ajpath.2007.060767 1:CAS:528:DC%2BD2sXlvFCnsbY%3D (Pubitemid 47339321)
25. DN Louis 1994 The p53 gene and protein in human brain tumors J Neuropathol Exp Neurol 53 1 11 21 8301315 10.1097/00005072-199401000-00002 1:CAS:528:DyaK2cXis1Kqs7o%3D (Pubitemid 24022082)
26. K Ueki Y Ono JW Henson JT Efird A von Deimling DN Louis 1996 CDKN2/p16 or RB alterations occur in the majority of glioblastomas and are inversely correlated Cancer Res 56 1 150 153 8548755 1:CAS:528:DyaK28Xit1ChtQ%3D%3D (Pubitemid 26010393)
27. G Konopka A Bonni 2003 Signaling pathways regulating gliomagenesis Curr Mol Med 3 1 73 84 12558076 10.2174/1566524033361609 1:CAS:528: DC%2BD3sXnvVOhtA%3D%3D (Pubitemid 36131679)
28. RE Smith HJ Zweerink WK Joklik 1969 Polypeptide components of virions, top component and cores of reovirus type 3 Virology 39 4 791 810 4311639 10.1016/0042-6822(69)90017-8 1:CAS:528:DyaE3cXltFSgtQ%3D%3D
29. CS Brown FM DiSumma J Rommelaere AY Dege JJ Cornelis C Dinsart WJ Spaan 2002 Production of recombinant H1 parvovirus stocks devoid of replication-competent viruses Hum Gene Ther 13 18 2135 2145 12542845 10.1089/104303402320987833 1:CAS:528:DC%2BD3sXosFymuw%3D%3D (Pubitemid 36418808)
30. HW Chucholowius R Rott 1972 A new method for purification of myxoviruses by zonal centrifugation with two different sucrose density gradients Proc Soc Exp Biol Med 140 1 245 247 5033100 1:STN:280:DyaE383gsFCisA%3D%3D
31. TC Chou P Talalay 1984 Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors Adv Enzyme Regul 22 27 55 6382953 10.1016/0065-2571(84)90007-4 1:CAS:528: DyaL2cXktlaksLk%3D
32. J Espada A Juarranz S Galaz M Canete A Villanueva M Pacheco JC Stockert 2005 Non-aqueous permanent mounting for immunofluorescence microscopy Histochem Cell Biol 123 3 329 334 15856278 10.1007/s00418-005-0769-2 1:CAS:528: DC%2BD2MXjs1Ols78%3D (Pubitemid 40674682)
33. YCM Herrero JJ Cornelis C Herold-Mende J Rommelaere JR Schlehofer K Geletneky 2004 Parvovirus H-1 infection of human glioma cells leads to complete viral replication and efficient cell killing Int J Cancer 109 1 76 84 10.1002/ijc.11626 (Pubitemid 38160665)
34. SM Oberhaus TS Dermody KL Tyler 1998 Apoptosis and the cytopathic effects of reovirus Curr Top Microbiol Immunol 233 Pt 2 23 49 9599930 1:CAS:528:DyaK1cXktFygt7o%3D
35. TJ Broering MM Arnold CL Miller JA Hurt PL Joyce ML Nibert 2005 Carboxyl-proximal regions of reovirus nonstructural protein muNS necessary and sufficient for forming factory-like inclusions J Virol 79 10 6194 6206 15858004 10.1128/JVI.79.10.6194-6206.2005 1:CAS:528:DC%2BD2MXkt1Witbw%3D (Pubitemid 40617224)
36. M Saifuddin CR Wilks NH Christensen ZF Fu M Rice 1989 Isolation of a reovirus from a broiler chicken flock with high early mortality NZ Vet J 37 1 12 14 10.1080/00480169.1989.35538 1:STN:280:DC%2BD2MzntlCitA%3D%3D
37. MM Arnold KE Murray ML Nibert 2008 Formation of the factory matrix is an important, though not a sufficient function of nonstructural protein mu NS during reovirus infection Virology 375 2 412 423 18374384 10.1016/j.virol.2008. 02.024 1:CAS:528:DC%2BD1cXlvF2rs7Y%3D
38. E Wang JA Connolly VI Kalnins PW Choppin 1979 Relationship between movement and aggregation of centrioles in syncytia and formation of microtubule bundles Proc Natl Acad Sci USA 76 11 5719 5723 293675 10.1073/pnas.76.11.5719 1:STN:280:DyaL3c7gtFCqsA%3D%3D (Pubitemid 10168678)
39. JS Parker TJ Broering J Kim DE Higgins ML Nibert 2002 Reovirus core protein mu2 determines the filamentous morphology of viral inclusion bodies by interacting with and stabilizing microtubules J Virol 76 9 4483 4496 11932414 10.1128/JVI.76.9.4483-4496.2002 1:CAS:528:DC%2BD38XivFGisLc%3D (Pubitemid 34309584)
40. ME Wilcox W Yang D Senger NB Rewcastle DG Morris PM Brasher ZQ Shi RN Johnston S Nishikawa PW Lee PA Forsyth 2001 Reovirus as an oncolytic agent against experimental human malignant gliomas J Natl Cancer Inst 93 12 903 912 11416111 10.1093/jnci/93.12.903 1:CAS:528:DC%2BD3MXltV2ltLY%3D (Pubitemid 32624647)
41. SD Loken K Norman K Hirasawa M Nodwell WM Lester DJ Demetrick 2004 Morbidity in immunosuppressed (SCID/NOD) mice treated with reovirus (dearing 3) as an anti-cancer biotherapeutic Cancer Biol Ther 3 8 734 738 15197356 10.4161/cbt.3.8.963 1:CAS:528:DC%2BD2MXhslKrtLg%3D (Pubitemid 41351077)
42. P Clarke SM Meintzer S Gibson C Widmann TP Garrington GL Johnson KL Tyler 2000 Reovirus-induced apoptosis is mediated by trail J Virol 74 17 8135 8139 10933724 10.1128/JVI.74.17.8135-8139.2000 1:CAS:528:DC%2BD3cXlsl2ns7g%3D (Pubitemid 30641660)
43. P Clarke KL Tyler 2003 Reovirus-induced apoptosis: a minireview Apoptosis 8 2 141 150 12766474 10.1023/A:1022966508671 1:CAS:528:DC%2BD3sXit12ksbw%3D (Pubitemid 36547101)
44. S Elankumaran D Rockemann SK Samal 2006 Newcastle disease virus exerts oncolysis by both intrinsic and extrinsic caspase-dependent pathways of cell death J Virol 80 15 7522 7534 16840332 10.1128/JVI.00241-06 1:CAS:528: DC%2BD28XnsVWgtLs%3D (Pubitemid 44092574)
45. Ravindra PV, Tiwari AK, Ratta B, Bais MV, Chaturvedi U, Palia SK, Sharma B, Chauhan RS (2009) Time course of newcastle disease virus-induced apoptotic pathways. Virus Res
46. RR Rosato JA Almenara Y Dai S Grant 2003 Simultaneous activation of the intrinsic and extrinsic pathways by histone deacetylase (HDAC) inhibitors and tumor necrosis factor-related apoptosis-inducing ligand (trail) synergistically induces mitochondrial damage and apoptosis in human leukemia cells Mol Cancer Ther 2 12 1273 1284 14707268 1:CAS:528:DC%2BD2cXnvFSr
47. JA Smith SC Schmechel BR Williams RH Silverman LA Schiff 2005 Involvement of the interferon-regulated antiviral proteins PKR and RNase l in reovirus-induced shutoff of cellular translation J Virol 79 4 2240 2250 15681426 10.1128/JVI.79.4.2240-2250.2005 1:CAS:528:DC%2BD2MXitlejtb0%3D (Pubitemid 40204581)
48. P Rudd G Lemay 2005 Correlation between interferon sensitivity of reovirus isolates and ability to discriminate between normal and Ras-transformed cells J Gen Virol 86 Pt 5 1489 1497 15831962 10.1099/vir.0.80628-0 1:CAS:528:DC%2BD2MXjvFSktLs%3D (Pubitemid 40613268)
49. C Fiola B Peeters P Fournier A Arnold M Bucur V Schirrmacher 2006 Tumor selective replication of Newcastle disease virus: association with defects of tumor cells in antiviral defence Int J Cancer 119 2 328 338 16470838 10.1002/ijc.21821 1:CAS:528:DC%2BD28XmsVOjtLw%3D
50. MA Garcia EF Meurs M Esteban 2007 The dsRNA protein kinase PKR: virus and cell control Biochimie 89 6-7 799 811 17451862 10.1016/j.biochi.2007.03.001 1:CAS:528:DC%2BD2sXnsFKrtbc%3D (Pubitemid 47001637)
51. Z Yue AJ Shatkin 1997 Double-stranded RNA-dependent protein kinase (PKR) is regulated by reovirus structural proteins Virology 234 2 364 371 9268168 10.1006/viro.1997.8664 1:CAS:528:DyaK2sXls1Omtrk%3D (Pubitemid 27360128)
52. MJ Clemens 1997 PKR-a protein kinase regulated by double-stranded RNA Int J Biochem Cell Biol 29 7 945 949 9375375 10.1016/S1357-2725(96)00169-0 1:CAS:528:DyaK2sXns1yksbs%3D (Pubitemid 27478880)
53. M Mora K Partin M Bhatia J Partin C Carter 1987 Association of reovirus proteins with the structural matrix of infected cells Virology 159 2 265 277 3617500 10.1016/0042-6822(87)90464-8 1:CAS:528:DyaL2sXltlSksro%3D
54. MM Becker TR Peters TS Dermody 2003 Reovirus sigma NS and mu NS proteins form cytoplasmic inclusion structures in the absence of viral infection J Virol 77 10 5948 5963 12719587 10.1128/JVI.77.10.5948-5963.2003 1:CAS:528: DC%2BD3sXjs1OksLs%3D (Pubitemid 36538986)
55. IH Maxwell KL Terrell F Maxwell 2002 Autonomous parvovirus vectors Methods 28 2 168 181 12413415 10.1016/S1046-2023(02)00221-9 1:CAS:528: DC%2BD38Xot1Kms7w%3D (Pubitemid 35341080)
56. M Vihinen-Ranta W Yuan CR Parrish 2000 Cytoplasmic trafficking of the canine parvovirus capsid and its role in infection and nuclear transport J Virol 74 10 4853 4859 10775624 10.1128/JVI.74.10.4853-4859.2000 1:CAS:528: DC%2BD3cXivFyns7s%3D (Pubitemid 30237913)